PHARMACEUTICAL INDUSTRY

 

Topics include: Orphan Drug Act of 1983, Drug Price Competition and Patent Term Restoration Act of 1984, Federal Anti-Tampering Act, Prescription Drug Marketing Act of 1987

 

See Also:                 Food and Drug Administration (FDA)

 

WHORM ALPHABETICAL FILE

Hayes, Arthur Hull

Young, Frank E.

 

WHORM SUBJECT FILE

 

BE001           147321, 175105, 178696

                                                  

BE003           159407

 

CM003          596697

 

FG               170721, 546073

 

FG017           129103

 

FG006-01      115884, 117256

 

FG006-07      209241, 209987, 209992, 219004, 236921

 

FI010-02        115778

 

HE               232295

 

HE006          064550, 077683, 108340, 109370, 111506, 115811, 115840, 116020, 116110, 116409, 116448, 116523, 116641, 116959, 117072, 117084, 117102, 117199, 117677, 120174, 120637, 122167, 123867, 124015, 128067, 133663, 138031, 159262, 164729, 233937, 235427, 247516, 248289, 261583, 262793,  264959, 267530, 303113, 328050, 541545, 554997, 558916, 558980, 559788, 559867, 559889, 578182, 578735, 581099, 611631

 

HE006-01      239135

 

JL003           113790, 169816

 

PR005-01      261152

 

PR012           111700, 120499, 184062, 249018, 256610, 266340, 266911, 278105

 

TA004-01      541544

 

WE001-01     115938

 

WHITE HOUSE STAFF AND OFFICE FILES

 

Buckalew, Judi: Files

OA 10227

Pharmacy, Pharmaceuticals

 

OA 10231

American Pharmaceutical Association Briefing 03/09/1984, 10:00 Room 175 (1)(2)

 

Council of Economic Advisers: Staff Economists: Files

          Series 101: B – Martin Zimmerman

OA 15323

Pharmaceuticals

 

Economic Policy Council: Records

CFOA 1319

Brazil Pharmaceuticals (1)-(5)

 

Executive Clerk, White House Office of the: Bill Reports

Box 33

10/13/1983 S.216 [Federal Anti-Tampering Act] (1)(2)

 

Box 40

09/24/1984 S.1538 [Drug Price Competition & Patent Term Registration Act of 1984]

 

First Lady, Office of the: Press Office

OA 18772

Pharmacists Against Drug Abuse (1)(2)

Pharmaceutical Manufacturers Association

 

Gunn, Wendell W.: Files

OA 9645

[Letter from Michael Geffrard (Pharmaceutical)]

 

Jacobi, Mary Jo: Files

OA 11929

Pharmaceutical Manufacturers Association

 

Knauer, Virginia H.: Files, Office of Public Liaison

OA 7362

Orphan Drug Act

 

OA 7364

Generic Pharmaceutical Industry Association

 

OA 7369

American Pharmaceutical Association

California Pharmacists Association

 

OA 7370

Missouri Pharmaceutical Association

Pharmaceutical Manufacturers Association

Pharmacopeial Convention, Inc.

 

Knauer, Virginia H.: Files, Office of Consumer Affairs

Box 1

Anti-Tampering Act (Federal)

 

Box 36

National Council for Prescription Drug Programs

 

Box 37

National Pharmaceutical Council, Inc.

 

Box 38

Pharmaceutical Manufacturers Association

 

Box 119

09/11/1985, Washington, DC – National Health Fraud Conference (FDA)

 

Box 120

06/02/1987, Philadelphia, PA – International Society of Pharmaceutical Engineers Sixth Annual Expo ‘87

 

Macdonald, Donald Ian: Files

OA 17000

Kappa Psi (Pharmaceutical Fraternity) 1234

 

OA 19055

Patient Package Inserts/FDA 1519

Pharmaceutical Manufacturers Association 09/23/1986 12:00 2805

 

OA 19361

Bezold, Clement, ed. Pharmaceuticals in the Year 2000: The Changing Context of Drug R&D, 1983 (book transferred to Book Collection)

 

McGrath, C. Dean: Files

CFOA 1134

Section 301 (Brazil Pharmaceuticals)

 

Meese, Edwin III: Files

OA 11853

Bezold, Clement, ed. Pharmaceuticals in the Year 2000: The Changing Context of Drug R&D, 1983 (book transferred to Book Collection)

 

Moore, Thomas G.: Files

OA 18898

Trade – Pharmaceuticals

 

Porter, Roger B.: Files

OA 15007

MOSS [Market Oriented Sector Selection Talks] – Meeting on Medical Equipment and Pharmaceuticals 08/20/1985 (1)-(11)

 

President, Office of the: Presidential Briefing Papers

09/24/1984 (casefile 292424)

 

Public Affairs, White House Office of: Records

OA 10448

Orphan Drug Act

 

Quint, Mary Elizabeth: Files

OA 8253

American Pharmaceutical Association Task Force on Women in Pharmacy (Washington, DC)

 

Risque, Nancy J.: Files: Office of Cabinet Secretary

OA 16066

Brazil Pharmaceutical Retaliation

 

Schnepper, Mary M.: Files

OA 15758

American Pharmaceutical Association

 

OA 15761

Pharmaceutical Manufacturers Association (1)(2)

Upjohn Pharmaceutical Company

 

OA 15764

Prescription Marketing Act Signing Ceremony (Oval Office)

 

Speechwriting, White House Office of: Speech Drafts: Records

Box 68

Signing Statement: Orphan Drug Act (Parvin) 01/04/1983

 

          Box 178

Signing Ceremony for Drug Price Competition & Patent Term Restoration Act of

1984 (Myer)(Timmons) 09/24/1984

 

Sprinkel, Beryl W.: Files

OA 17748

04/14/1986 (1:00pm) Roosevelt Room – EPC Meeting on Canadian Pharmaceuticals and Thrifts

 

Turner, Carlton E.: Files

Box 8

American Foundation for Pharmaceutical Education

 

Box 9

American Pharmaceutical Association

 

Box 10

Anti-Tampering

 

Box 24

Dick Eisenger re: KV Pharmaceutical Methadone Program 06/09/1983 3:45pm (1)(2)

 

Box 38

McNeil Pharmaceutical’s Brochure – (PADA) [Pharmacists against Drug Abuse]: The Kinds of Drugs Kids Are Getting Into (1)(2)

 

Box 39

McNeil Pharmaceutical’s Brochure – (PADA) [Pharmacists against Drug Abuse]: The Kinds of Drugs Kids Are Getting Into (3)-(5)

 

Box 40

Merrell-Dow Pharmaceutical, Joe Stetler 11/01/1983

 

Box 47

National Pharmaceutical Council

 

Box 51

Dr. Harry Pars, SISA Pharmaceuticals 08/17/1984 2:30pm

 

Box 52

Pharmaceutical Firms

Pharmaceutical Industry - Washington, D. C., 10/20/1983 – Breakfast

Pharmaceutical Manufacturers Association, 09/23/1986 - 12:00 pm

Pharmaceutical Manufacturers Association – Jill Schuker, 03/29/1983 - 4:00 pm (1)-(3)

PADA [Pharmacists Against Drug Abuse] (1)(2)

Pharmacy International [1981-1983] (1)-(4)

Pharmacy International [1984]

Pharmacy Robbery - Justice Report on S.109, S.422, and S.721

Pharmacy Times (1)-(3)

 

          Box 53

PharmChem Laboratories / California – Charles Renfroe

 

Box 57

[Research Institute of Pharmaceutical Sciences, University of Mississippi]

 

Box 73

H.R. 5238 Orphan Drug Act 97th Congress 01/25/1982

 

Box 84

DC Pharmaceutical Association 05/31/1986 1102 (1)(2)

 

Box 85

Pharmaceutical Wholesalers 11/20/1981-11/23/1981 Mexico City

 

Waller, David B.: Files

OA 12682

          Subject File: [September 1984; Tabs 20-31; Second Series Tabs 1-6]

                   (Relevant material: S. 1538 Drug Price Competition & Patent Term 09/21/1984)

 

Subject File: [June 1985; Tabs 24-31]

(Relevant material: Hoechst-Roussel Pharmaceuticals Inc. & Glaxo Inc., - Lester Hyman 06/06/1985)

 

Last Updated: 2/11/2014                                                                                     Most Recent Opening: 12/31/2011

 

Case#                      Researcher                            Topic                                                       Pages      Restricted              

F06-039/1               Richert                                    Pharmceutical Industry                         4360        176         

F06-060/2               Potter                                     Carlton Turner Files                              4801        16 whole, 11 partial

F06-039/2               Richert                                    FDA/Pharmaceutical Industry              664          13